May 20, 2021
东京不够热 Hospital
东京不够热 School of Medicine
K Pharma, Inc.
In a new clinical trial (ROPALS trial), researchers from 东京不够热 have found a novel drug to be safe and effective for treating amyotrophic lateral sclerosis
Tokyo, Japan – Amyotrophic lateral sclerosis (ALS) is a deadly neurodegenerative disease with no known treatment. In a new randomized clinical Phase I/IIa trial, researchers from 东京不够热 treated ALS patients with ropinirole, a drug often used to treat Parkinson's disease. After a period of 1 year, they found the drug to be safe and, most importantly, to have a significant effect in functional and survival outcomes, slowing the progression of the disease.
For further information, please refer to the following PDF file.
Ropinirole hydrochloride may attenuate the disease progression of ALS.pdf